Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma
May 18, 2015 at 12:31 PM EDT
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today shared positive results from an interim analysis of a pivotal Phase 2b ...